OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis
Kosuke Takemura, Satoru Yonekura, Laura Downey, et al.
European Urology Open Science (2022) Vol. 39, pp. 62-71
Open Access | Times Cited: 18
Kosuke Takemura, Satoru Yonekura, Laura Downey, et al.
European Urology Open Science (2022) Vol. 39, pp. 62-71
Open Access | Times Cited: 18
Showing 18 citing articles:
Skeletal muscle and visceral adipose radiodensities are pre‐surgical, non‐invasive markers of aggressive kidney cancer
Helena Furberg, Patrick T. Bradshaw, Andrea Knežević, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 2, pp. 726-734
Open Access | Times Cited: 7
Helena Furberg, Patrick T. Bradshaw, Andrea Knežević, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 2, pp. 726-734
Open Access | Times Cited: 7
Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox
Logan V. Vick, Spencer R. Rosario, Jonathan W. Riess, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Logan V. Vick, Spencer R. Rosario, Jonathan W. Riess, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Prognostic and predictive importance of body mass index and type 2 diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
Oliver John Kennedy, Nina Glassée, Michal Kiciński, et al.
EJC Skin Cancer (2025), pp. 100284-100284
Open Access
Oliver John Kennedy, Nina Glassée, Michal Kiciński, et al.
EJC Skin Cancer (2025), pp. 100284-100284
Open Access
The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms
Andrew W. Hahn, Neha Venkatesh, Pavlos Msaouel, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2551-2551
Open Access | Times Cited: 11
Andrew W. Hahn, Neha Venkatesh, Pavlos Msaouel, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2551-2551
Open Access | Times Cited: 11
Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies
Keigo Sato, Kosuke Takemura, Ryosuke Oki, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Keigo Sato, Kosuke Takemura, Ryosuke Oki, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium
Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, et al.
International Journal of Clinical Oncology (2025)
Closed Access
Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, et al.
International Journal of Clinical Oncology (2025)
Closed Access
Obesity, the Adipose Organ and Cancer in Humans: Association or Causation?
Elisabetta Trevellin, Silvia Bettini, Anna Pilatone, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 10
Elisabetta Trevellin, Silvia Bettini, Anna Pilatone, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 10
Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
Alexander Hintze Hillers, Signe Wang Bach, A Saito, et al.
BJUI Compass (2024) Vol. 5, Iss. 8, pp. 783-790
Open Access | Times Cited: 3
Alexander Hintze Hillers, Signe Wang Bach, A Saito, et al.
BJUI Compass (2024) Vol. 5, Iss. 8, pp. 783-790
Open Access | Times Cited: 3
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Impact of BMI on the Survival of Renal Cell Carcinoma Patients Treated with Targeted Therapy: A Systematic Review and Meta-Analysis
Junjie Ji, Yu Yao, Fengju Guan, et al.
Nutrition and Cancer (2023) Vol. 75, Iss. 9, pp. 1768-1782
Open Access | Times Cited: 4
Junjie Ji, Yu Yao, Fengju Guan, et al.
Nutrition and Cancer (2023) Vol. 75, Iss. 9, pp. 1768-1782
Open Access | Times Cited: 4
A Nomogram Including Sarcopenia for Predicting Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma: A Retrospective Cohort Study
Wenhui Su, Yukun Wu, Shufen Liao, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 9, pp. 5815-5826
Closed Access | Times Cited: 1
Wenhui Su, Yukun Wu, Shufen Liao, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 9, pp. 5815-5826
Closed Access | Times Cited: 1
Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors
Ji Eun Park, Jaemin Jo, Jeonghwan Youk, et al.
Insights into Imaging (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Ji Eun Park, Jaemin Jo, Jeonghwan Youk, et al.
Insights into Imaging (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The Prognostic Role of Body Mass Index on Oncological Outcomes of Upper Tract Urothelial Carcinoma
Kang Liu, Hongda Zhao, Chi‐Fai Ng, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5364-5364
Open Access | Times Cited: 3
Kang Liu, Hongda Zhao, Chi‐Fai Ng, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5364-5364
Open Access | Times Cited: 3
Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis
Kunwoo Lee, Jiwoong Yu, Wan Song, et al.
Investigative and Clinical Urology (2024) Vol. 65, Iss. 5, pp. 423-423
Open Access
Kunwoo Lee, Jiwoong Yu, Wan Song, et al.
Investigative and Clinical Urology (2024) Vol. 65, Iss. 5, pp. 423-423
Open Access
Exploring the causal relationship between omega-3 and omega-6 fatty acids and kidney cancer: a Mendelian randomization study
Weifeng Liu, Yufei Wang, Yibin Zhou
Translational Cancer Research (2024) Vol. 13, Iss. 4, pp. 1685-1694
Open Access
Weifeng Liu, Yufei Wang, Yibin Zhou
Translational Cancer Research (2024) Vol. 13, Iss. 4, pp. 1685-1694
Open Access
Data from Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Data from Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Prognostic Factors in Advanced Renal Cell Carcinoma
Kosuke Takemura, Vishal Navani, Daniel Y.C. Heng, et al.
Springer eBooks (2023), pp. 233-250
Closed Access
Kosuke Takemura, Vishal Navani, Daniel Y.C. Heng, et al.
Springer eBooks (2023), pp. 233-250
Closed Access
